EMA UPDATES ITS ANTI-CANCER MEDICINE GUIDANCE
March 1st, 2016
THE EUROPEAN Medicines Agency (EMA) has updated its guidance on evaluating anticancer medicinal products for humans, so that pharmacos are better able to develop and assess treatments for leukaemia. The agency recommends that quality management systems be established that include organisational structure, responsibilities, policies and standards. These are needed to ensure accuracy and satisfactory quality of evaluation assays trying to establish whether cancer cells have destroyed. All local laboratories within a clinical trial should undergo inter-laboratorial ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.